Henry Meds vs Ro

Which is actually cheaper — the all-in monthly math

Henry Meds keeps this simple: one flat number covers the provider visit, the compounded medication, and shipping, whether you pick oral or injectable. That range runs from $249 a month for oral semaglutide up to $449 a month for injectable tirzepatide — roughly $2,988 to $5,388 a year — and the price doesn't climb as your dose does.

Ro's math has two moving parts. The Body membership costs $149 a month on its own, after a discounted first month, and every medication is billed separately on top of it. Add the cheapest branded option — the Wegovy Pill at its lowest tier — and you're around $298 a month. Add Zepbound at a higher dose and the same membership pushes the bill toward $598 a month. Stretched across a year, Ro lands somewhere between roughly $3,500 and about $7,200, depending entirely on which drug and dose you end up on.

The practical takeaway: Henry Meds is cheaper at every comparable tier, and its price is also the whole price. Ro's advertised medication cost is only half of what you'll actually pay — the membership isn't optional, and it's easy to miss on a pricing page that leads with the drug.

Compounded vs. FDA-approved: does it actually matter

This is the real fork between these two companies, more than price. Henry Meds fills every prescription through a network of 503A compounding pharmacies — pharmacies licensed to prepare a medication for one named patient against one specific prescription, rather than manufacturing a mass-produced, FDA-approved drug. Ro made the opposite bet: every medication on its menu, from the Wegovy Pill to Zepbound, is an FDA-approved finished drug product, made by Novo Nordisk or Eli Lilly and dispensed through licensed retail or LillyDirect channels.

The regulatory ground under compounded GLP-1s has been shifting through 2026. The FDA proposed in April to remove semaglutide, tirzepatide, and liraglutide from the list of drugs 503B outsourcing facilities can compound in bulk, with finalization expected around the third quarter of the year. Henry Meds' 503A model sits in a narrower but still legal lane — a 503A pharmacy generally can't compound a near-identical copy of a commercially available drug on a routine, large-scale basis, which is the compliance line every 503A GLP-1 compounder is now working around. It's also worth knowing, if you're weighing legitimacy questions, that Henry Meds is a named defendant in an ongoing Eli Lilly lawsuit over marketing language — a civil dispute, not a fraud finding or FDA enforcement action; the full record is broken down here if you want it.

None of that makes compounded medication unsafe by definition, and it doesn't make Ro's branded drugs inherently better for you personally. It does mean the two paths carry genuinely different risk profiles: Ro's is a supply-chain and regulatory certainty you're paying for, and Henry Meds' is a lower price with a compounding landscape that could look different by the time you renew.

Insurance: what each one will (and won't) bill

Neither company bills insurance for its own membership or clinical fee — that part is cash-pay everywhere in this category. The difference shows up in the medication. Compounded semaglutide and tirzepatide are never covered by insurance, at Henry Meds or anywhere else, so HSA and FSA cards, where your plan allows it, are the only way to soften that cost.

Ro's medications are a different story, because they're FDA-approved and carry real NDC codes insurers recognize. Ro's membership includes an insurance concierge that actively works prior authorization and appeals for Wegovy and Zepbound — and if your plan covers either drug, that can drop your medication cost to a copay while the $149 membership becomes the main line item left. For someone with employer insurance that includes weight-loss drug coverage, that single fact can flip the entire cost comparison in Ro's favor.

Medication options and formats: what you're actually choosing between

Henry Meds offers four combinations: oral or injectable semaglutide, oral or injectable tirzepatide. That needle-free option in both molecules is a real point in its favor for anyone who's put off starting a GLP-1 specifically because of the injection.

Ro's menu is narrower but still covers the medications most people are actually asking for: the Wegovy Pill (the only FDA-approved oral semaglutide for weight management), the original Wegovy Pen injection, Zepbound through Eli Lilly's LillyDirect program, and off-label Ozempic in select cases where insurance drives that choice. Tirzepatide's dual GLP-1/GIP mechanism is associated with greater average weight loss than semaglutide alone in published trials, which is part of why Zepbound — available through Ro but not offered in compounded form there — is often the medication patients specifically ask for by name.

What's bundled — labs, coaching, and support

This is where Ro's higher price buys something concrete beyond the drug itself. Routine labs, a dedicated health coach, and the insurance-navigation help described above are all folded into the $149 monthly membership, with no separate line item.

Henry Meds' price covers the provider relationship and the medication — ongoing access for dose questions and follow-up is included — but not labs or coaching. You'll need to arrange your own bloodwork through a primary care provider or an independent lab, and there's no built-in coaching layer. For a patient who already has a doctor ordering routine labs anyway, that gap barely matters. For someone starting from zero, it's a real cost and coordination task Ro would otherwise absorb.

Neither is built for menopause specifically — here's the gap

Worth saying plainly: neither Henry Meds nor Ro is a menopause program. Both intake processes ask about general medical history, not hormonal status, and neither adjusts its GLP-1 protocol for perimenopause or menopause specifically. If your weight gain has a real hormonal driver running alongside the metabolic shifts a GLP-1 can address, a GLP-1 alone — from either company — is treating one part of the picture, not the whole thing.

Women who want GLP-1 therapy paired with menopause-literate hormonal care will generally need two separate relationships: a GLP-1 provider like one of these, and a hormone-focused clinician. The full menopause telehealth comparison is a reasonable place to start if that pairing is what you're after.

State coverage and how each handles cancellation

Henry Meds operates in all 50 states and lets you cancel any time with no fee — it's a month-to-month plan with nothing to unwind beyond stopping your next shipment.

Ro is available in most states, but not universally, and which medications and pharmacy options apply can vary by where you live — the eligibility check during signup is the reliable way to confirm your state rather than any general list. Canceling requires contacting Ro's support directly rather than a self-service toggle, and you'll want to do it at least 48 hours before your renewal date to avoid being billed for another cycle.

The real difference

This isn't a better-and-worse comparison so much as two different bets. Henry Meds bets on transparent, flat, compounded pricing — you know your exact monthly number on day one, and it stays that way as your dose changes. Ro bets on FDA-approved certainty and a fuller support package — labs, coaching, insurance help — at a real premium, one that can shrink dramatically if your insurance actually covers the drug. If cost predictability and needle-free options matter most, Henry Meds is the more straightforward pick. If you specifically want a branded, FDA-approved medication or have insurance worth fighting for, Ro's membership is buying you something real.